Physician profile
Ryan Werntz
NPI 1295274017
$19,255.56
in general payments reported to CMS, 2019-2025
10 companies · $3,907 in 2025
The $3,907 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $870 · 2021: $2,880 · 2022: $1,183 · 2023: $4,479 · 2024: $5,937 · 2025: $3,907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,540 · Travel and Lodging: $6,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,540.07 |
| Travel and Lodging | $6,782.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,445.47 | 2021-2025 | Journey II, Real Intelligence, Legion Revision |
| Stryker Corporation | $4,030.49 | 2022-2025 | Mako, Pangea, Variax |
| Southern Edge Orthopaedics, INC. | $2,070.00 | 2020-2021 | |
| Depuy Synthes Sales INC. | $607.63 | 2022-2024 | Na, Motoband, Tfn-Advance |
| Exactech, INC. | $439.68 | 2021-2024 | |
| Biocomposites INC | $275.48 | 2022-2025 | Stimulan |
| Sanara Medtech INC. | $137.66 | 2023 | Celleraterx |
| Kerecis Limited | $129.14 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Zimmer Biomet Holdings, INC. | $74.90 | 2024 | Arcos |
| Baudax Bio INC. | $45.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Werntz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.